Back to News
Market Impact: 0.3
Neuronetics, Inc. Reports Third Quarter 2026 Financial and Operating Results
Source: Nasdaq
Corporate EarningsCompany FundamentalsHealthcare & Biotech
Neuronetics reported Q3 2026 revenue of $42.0 million, up 12.5% year over year. Greenbrook revenue rose 20.1% to $26.2 million and was the primary driver of growth; the provided article text contains no further results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
STIM0.45
More News
- NextDC shares surge 43% after Goodman, Digital Realty stake purchases
- Asian chip stocks slide as disappointing Qualcomm, Arm earnings weigh
- Snap shares fall over 10% on third-quarter earnings miss
- ‘Seismic’ blue wave triggers the sinking of oil prices, energy stocks, and the chances of power permitting reform
- Softbank’s $5.4 bln takeover of ABB robotics unit blocked by China- FT
- Qualcomm issues disappointing earnings forecast as memory shortage weighs on smartphone sales